Mary Kendall Rago, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 301 Ohio River Blvd, Suite 202, Sewickley, PA 15143 Phone: 412-741-2122 Fax: 412-741-5417 |
Dr. Matthew Burrill Straka, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1099 Ohio River Blvd, Sewickley, PA 15143 Phone: 412-741-5670 Fax: 412-741-8520 |
Dr. Shelly Jeanne Mcquone, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1099 Ohio River Blvd, Sewickley, PA 15143 Phone: 412-741-5670 Fax: 412-741-8520 |
Dr. Deborah Anderson Eaton, MD Otolaryngology - Otology & Neurotology Medicare: Accepting Medicare Assignments Practice Location: 1099 Ohio River Blvd, Sewickley, PA 15143 Phone: 412-741-5670 Fax: 412-741-8520 |
Michael A Orsini, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 301 Ohio River Blvd, Edgeworth Medical Commons Suite 202a, Sewickley, PA 15143 Phone: 412-741-2122 Fax: 412-741-5417 |
Stephen M Froman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 301 Ohio River Blvd, Suite 202 Edgeworth Medical Commons, Sewickley, PA 15143 Phone: 412-741-2122 Fax: 412-741-5417 |
Dr. William A Marasovich, MD DDS Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 701 Broad St, Suite D, Sewickley, PA 15143 Phone: 412-741-2123 |
Dr. John Anthony Straka, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1099 Ohio River Blvd, Sewickley, PA 15143 Phone: 412-741-5670 Fax: 412-741-8520 |
News Archive
Ghanaian Obstetrics and Gynecology residents say in-country training programs contributed to their decision to remain in their home country to practice medicine, new University of Michigan research shows.
Scientists from the Florida campus of The Scripps Research Institute have identified a protein complex that plays a critical but previously unknown role in learning and memory formation.
A new disposable device based on advances in microfluidics may help identify advanced breast cancer patients who are candidates for therapy with the drug trastuzumab (Herceptin). The device is described in the American Institute of Physics' journal Biomicrofluidics.
Transgenomic, Inc. today announced that Jeana DaRe, Ph.D., Assistant CLIA Laboratory Director at Transgenomic, presented clinical findings from patients tested for nuclear mitochondrial disorders using Transgenomic's NuclearMitome Test on Thursday, March 29, at the 2012 Annual Meeting of the American College of Medical Genetics (ACMG) in Charlotte, North Carolina.
A team of researchers working at the University of Bristol has found a potential new treatment for listeriosis, a deadly form of food poisoning. Their work is reported in Nature Medicine.
› Verified 4 days ago